000 01588 a2200421 4500
005 20250516152930.0
264 0 _c20140331
008 201403s 0 0 eng d
022 _a1950-6007
024 7 _a10.1016/j.biopha.2013.04.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBraga, Marina Souza
245 0 0 _aVascular endothelial growth factor as a biomarker for endostatin gene therapy.
_h[electronic resource]
260 _bBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_cJul 2013
300 _a511-5 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiogenesis Inhibitors
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCarcinoma, Renal Cell
_xgenetics
650 0 4 _aCollagen Type XVIII
_xgenetics
650 0 4 _aEndostatins
_xgenetics
650 0 4 _aGenetic Therapy
_xmethods
650 0 4 _aKidney Neoplasms
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aRNA, Messenger
_xgenetics
650 0 4 _aVascular Endothelial Growth Factor A
_xgenetics
700 1 _aTuraça, Thiago Lauro
700 1 _aFoguer, Karen
700 1 _aChaves, Karen Cristina Barbosa
700 1 _aPesquero, João Bosco
700 1 _aChammas, Roger
700 1 _aSchor, Nestor
700 1 _aBellini, Maria Helena
773 0 _tBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
_gvol. 67
_gno. 6
_gp. 511-5
856 4 0 _uhttps://doi.org/10.1016/j.biopha.2013.04.008
_zAvailable from publisher's website
999 _c22798838
_d22798838